C-met activation is necessary but not sufficient for liver colonization by B16 murine melanoma cells

Clinical and Experimental Metastasis

Volumn 16, Issue 3, 1998, Pages 253-265

  Lin, Shuo ^a   Rusciano, Dario ^a   Lorenzoni, Patrizia ^a   Hartmann, Guido ^b   Birchmeier, Walter ^b   Giordano, Silvia ^c   Comoglio, Paolo ^c   Burger, Max M ^a  

^a FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RESEARCH   (Switzerland)

^b MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^c CANDIOLO CANCER INSTITUTE   (Italy)

Author keywords

B16 melanoma; C met; HGF SF; Liver metastasis

Indexed keywords

ANIMAL CELL; ANIMAL MODEL; ARTICLE; DNA TRANSFECTION; GENE ACTIVATION; GENE OVEREXPRESSION; LIVER METASTASIS; MELANOMA; MELANOMA B16; METASTASIS POTENTIAL; NONHUMAN; ONCOGENE;

ANIMALS; AUTOCRINE COMMUNICATION; ENZYME ACTIVATION; HEPATOCYTE GROWTH FACTOR; HUMANS; LIVER NEOPLASMS; LUNG NEOPLASMS; MELANOMA; MICE; NEOPLASM METASTASIS; PHOSPHOTYROSINE; PROTO-ONCOGENE PROTEINS C-MET; TUMOR CELLS, CULTURED;

EID: 0031918864     PISSN: 02620898     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006596909948     Document Type: Article

References (51)

1. Kemeny NE, Kemeny M and Lawrence TS. 1995, Liver metastasis. In: Abeloff MD, Armitage JO, Lichter AS and Niederhuber JE, eds. Clinical Oncology. New York: Churchill Livingstone, pp. 679-707.
2. Fidler IJ and Hart IR. 1982, Biological diversity in metastatic neoplasms: origins and implications. Science, 217, 998-1003.
3. Sargent NSE, Oestreicher M, Haidvogl H, Madnick HM and Burger MM. 1988, Growth regulation of cancer metastases by their host organ. Proc Natl Acad Sci USA, 85, 7251-55.
4. Nicolson GL. 1991, Tumor and host molecules important in the organ preference of metastasis. Sem Cancer Biol, 2, 143-54.
5. Rusciano D and Burger MM. 1992, Why do cancer cells metastasize into particular organs? BioEssays, 14, 185-94.
6. Nakamura T, Nishizawa T, Hagiya M et al. 1989, Molecular cloning and expression of human hepatocyte growth factor. Nature, 342, 440-43.
7. Michalopoulos GK and Zarnegar R. 1992, Hepatocyte growth factor. Hepatol, 15, 150-55.
8. Zarnegar R and Michalopoulos GK. 1995, The many faces of Hepatocyte Growth Factor, from hepatopoiesis to hematopoiesis. J Cell Biol, 129, 1177-80.
9. Bottaro DP, Rubin JS, Faletto DL et al. 1991, Identification of the hepatocyte growth factor receptor as the c-met protooncogene product. Science, 251, 802-4.
10. Weidner KM, Sachs M and Birchmeier W. 1993, The met receptor tyrosine kinase transduces motility, proliferation and morphogenetic signals of scatter factor/hepatocyte growth factor in epithelial cells. J Cell Biol, 21, 145-54.
11. Komada M and Kitamura N. 1993, The cell dissociation and motility triggered by scatter factor/hepatocyte growth factor are mediated through the cytoplasmic domain of the c-met receptor. Oncogene, 8, 2381-90.
12. Rong S, Bodescot M, Blair D et al. 1992, Tumori-genicity of the met proto-oncogene and the gene for hepatocyte growth factor. Mol Cell Biol, 12, 5152-58.
13. Rong S, Segal S, Anver M, Resau JH and Vande Woude GF. 1994, Invasiveness and metastasis of NIH 3T3 cells induced by met-hepatocyte growth factor/scatter factor autocrine stimulation. Proc Natl Acad Sci USA, 91, 4731-35.
14. Giordano S, Zhen Z, Medico E, Gaudino G and Comoglio PM. 1993, Transfer of motogenic and invasive response to scatter factor/hepatocyte growth factor by transfection of human met proto-oncogene. Proc Natl Acad Sci USA, 90, 649-53.
15. Rusciano D, Lorenzoni P and Burger MM. 1993, Paracrine growth response as a major determinant in liver-specific colonization by in vivo selected B16 murine melanoma cells. Invasion Metastasis, 13, 212-24.
16. Rusciano D, Lorenzoni P and Burger MM. 1995, Expression of constitutively activated hepatocyte growth factor/scatter factor receptor (c-met) in B16 melanoma cells selected for enhanced liver colonization. Oncogene, 11, 1979-87.
17. Rusciano D, Lorenzoni P and Burger MM. 1996, Constitutive activation of c-met in liver metastatic B16 melanoma cells depends on both substrate adhesion and cell density and is regulated by a cytosolic tyrosine phosphatase activity. J Biol Chem, 271, 20763-69.
18. Dean M, Park and Wande Woude GF. 1987, Characterization of the rearranged tpr-met oncogene break-point. Mol Cell Biol, 7, 921-24.
19. Hartmann G, Naldini L, Weidner KM et al. 1992, A functional domain in the heavy chain of scatter factor/hepatocyte growth factor binds the c-met receptor and induces cell dissociation but not mitogenesis. Proc Natl Acad Sci USA, 89, 11574-78.
20. Prat M, Narsimhan RP, Crepaldi T et al. 1991, The receptor encoded by the human c-met oncogene is expressed in hepatocytes, epithelial cells and solid tumors. Int J Cancer, 49, 323-28.
21. Leoncini L, Pacenti L, Rusciano D et al. 1988, Correlation between differentiation and lung colonization by retinoic acid-treated F9 cells as revealed by the expression pattern of extracellular matrix and cell surface antigens. Am J Pathol, 130, 505-14.
22. Wolf HK, Zarnegar R and Michalopoulos GK. 1991, Localization of hepatocyte growth factor in human and rat tissue. Hepatol, 14, 488-94.
23. Tashiro K, Hagiya M, Nishizawa T et al. 1990, Deduced primary structure of rat hepatocyte growth factor and expression of the mRNA in rat tissue. Proc Natl Acad Sci USA, 87, 3200-4.
24. Kagoshima M, Kinoshita T, Matsumoto K and Nakamura T. 1992, Developmental changes in hepatocyte growth factor mRNA and its receptor in rat liver, kidney and lung. Eur J Biochem, 210, 375-380.
25. Zarnegar R, DeFrances MC, Kost DP, Lindroos P and Michalopoulos GK. 1991, Expression of hepatocyte growth factor mRNA in regenerating rat liver after partial hepatectomy. Biochem Biophys Res Commum, 177, 559-65.
26. Yanagita K, Matsumoto K, Sekiguchi K et al. 1993, Hepatocyte growth factor may act as a pulmotrophic factor on lung regeneration after acute lung injury. J Biol Chem, 268, 21212-17.
27. Kawaida K, Matsumoto K, Shimazu H and Nakamura T. 1994, Hepatocyte growth factor prevents renal failure and accelerates renal regeneration in mice. Proc Natl Acad Sci USA, 91, 4357-61.
28. Tomiya T, Nagoshi S and Fujiwara K. 1992, Significance of serum hepatocyte growth factor levels in patients with hepatic failure. Hepatol, 15, 1-4.
29. Yoshinaga Y, Matsuno Y, et al. 1993, Immunohistochemical detection of hepatocyte growth factor/scatter factor in human cancerous and inflammatory lesions of various organs. Jpn J Cancer Res, 84, 1150-58.
30. Eagles G, Warn A, Ball RY et al. 1996, Hepatocyte growth factor/scatter factor is present in most pleural effusion fluids from cancer patients. Br J Cancer, 73, 277-381.
31. Taniguchi T, Toi M, Inada K et al. 1995, Serum concentrations of hepatocyte growth factor in breast cancer patients. Clin Cancer Res, 1, 1031-34.
32. Di Renzo MF, Narshiman RP, Olivero M et al. 1991, Expression of the Met/HGF receptor in normal and neoplastic human tissues. Oncogene, 6, 1997-2003.
33. Radinsky R, Risin S, Fan D et al. 1995, Level and function of epidermal growth factor receptor predict the metastatic potential of human colon carcinoma cells. Clin Cancer Res, 1, 19-31.
34. Grigioni WF, Fiorentino M, D'Errico A et al. 1995, Overexpression of c-met protooncogene product and raised Ki67 index in hepatocellular carcinomas with respect to benign liver conditions. Hepatol, 21, 1543-46.
35. Natali PG, Nicotra MR, Di Renzo MF et al. 1993, Expression of the C-Met/HGF receptor in human melanocytic neoplasms, demonstration of the relationship to malignant melanoma tumor progression. Br J Cancer, 68, 746-50.
36. Tuck AB, Park M, Sterns EE, Boag A and Elliott BE. 1996, Coexpression of Hepatocyte Growth Factor and receptor (met) in human breast carcinoma. Am J Pathol, 148, 225-32.
37. Di Renzo MF, Olivero M, Katsaros D et al. 1994, Overexpression of the Met/HGF receptor in ovarian cancer. Int J Cancer, 58, 658-62.
38. Hasegawa Y, Yamamoto M, Maeda S and Saitoh Y. 1995, Hepatocyte Growth Factor and its receptor c-met regulate both cell growth and invasion of human pancreatic cancer. Int J Oncol, 7, 877-81.
39. Humphrey PA, Zhu X, Zarnegar R et al. 1995, Hepatocyte Growth Factor and its receptor (c-met) in prostatic carcinoma. Am J Pathol, 147, 386-96.
40. Ferracini R, Di Renzo MF, Scotlandi K et al. 1995, The MET/HGF receptor is overexpressed in human osteosarcomas and is activated by either a paracrine or an autocrine circuit. Oncogene, 10, 739-49.
41. Di Renzo MF, Olivero M, Giacomini A et al. 1995, Overexpression and amplification of the Met/HGF receptor gene during the progression of colorectal cancer. Clin Cancer Res, 1, 147-54.
42. Cooper CS, Park M, Blair DG et al. 1984, Molecular cloning of a new transforming gene from a chemically transformed human cell line. Nature, 311, 29-33.
43. Soman NR, Correa P, Ruiz BA and Wogan GN. 1991, The tpr-met oncogenic rearrangement is present and expressed in human gastric carcinoma and precursor lesions. Proc Natl Acad Sci USA, 88, 4892-96.
44. Soman NR, Wogan GN and Rhim JS. 1990, Tpr-met oncogenic rearrangement, detection by pcr amplification of the transcript and expression in human tumor cell lines. Proc Natl Acad Sci USA, 87, 738-42.
45. Gonzatti-Haces M, Seth A, Park M et al. 1988, Characterization of the TPR-MET oncogene p65 and the MET protooncogene p140 protein-tyrosine kinases. Proc Natl Acad Sci USA, 85, 21-25.
46. Jeffers M, Rong S and Vande Woude GF. 1996, Enhanced tumorigenicity and invasion-metastasis by HGF/SF-met signalling in human cells concomitant with induction of the urokinase proteolysis network. Mol Cell Biol, 16, 1115-25.
47. Yayon A and Klagsbrun M. 1990, Autocrine regulation of cell growth and transformation by basic fibroblast growth factor. Cancer Metastasis Rev, 9, 191-202.
48. Damen JE, Greenberg AH and Wright JA. 1991, Transformation and amplification of the K-fgf protooncogene in NIH3T3 cells, and induction of metastatic potential. Biochim Biophys Acta, 1097, 103-10.
49. Yu D, Hamada J, Zhang H, Nicolson GL and Hung MC. 1992, Mechanisms of c-erbB2/neu oncogene-induced metastasis and repression of metastatic properties by adenovirus 5 E1A gene products. Oncogene, 7, 2263-70.
50. Yu D, Wang SS, Dulski KM et al. 1994, C-erbB2/neu overexpression enhances metastatic potential of human lung cancer cells by induction of metastasis-associated properties. Cancer Res, 54, 3260-66.
51. Guy CT, Webster MA, Schaller M et al. 1992, Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease. Proc Natl Acad Sci USA, 89, 10578-82.